Acceleron Pharma
XLRN
#1575
Rank
โ‚ฌ10.42 B
Marketcap
170,42ย โ‚ฌ
Share price
0.00%
Change (1 day)
15,708.57%
Change (1 year)

Revenue for Acceleron Pharma (XLRN)

Revenue in 2021 (TTM): โ‚ฌ95.1 Million

According to Acceleron Pharma's latest financial reports the company's current revenue is โ‚ฌ0.10 Billion. In 2020 the company made a revenue of โ‚ฌ88.21 Million an increase over the revenue in the year 2019 that were of โ‚ฌ70.54 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Acceleron Pharma from 2012 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ95.1 M7.81%
2020โ‚ฌ88.21 M25.05%
2019โ‚ฌ70.54 M428.85%
2018โ‚ฌ13.33 M3.78%
2017โ‚ฌ12.85 M-51.45%
2016โ‚ฌ26.47 M53.47%
2015โ‚ฌ17.25 M23.68%
2014โ‚ฌ13.94 M-74.43%
2013โ‚ฌ54.56 M275.17%
2012โ‚ฌ14.54 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ31.01 B 28,751.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.20 B 12,179.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.60 B 77,669.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.21 M-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ11.7 M-89.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ52.34 M-51.31%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.04 B 49,243.76%๐Ÿ‡บ๐Ÿ‡ธ USA